Navidea Biopharmaceuticals Initiates Enrollment in Global Phase 3 Trial of NAV4694 PET Imaging Agent Jun 27, 2013
Navidea Biopharmaceuticals Closes $25 Million Debt Financing with GE Capital, Healthcare Financial Services Jun 26, 2013
Navidea Biopharmaceuticals Announces Presentation of Meta-Analysis Results of Lymphoseek® and ACOSOG Radiolabeled Colloid in Head and Neck Cancer Jun 12, 2013
Navidea Biopharmaceuticals Announces Results from Lymphoseek® Study on Accuracy of Lymph Node Detection from Injection Time to Surgery Jun 11, 2013
Navidea Biopharmaceuticals Announces Presentation of Results from Two Lymphoseek® and Radiolabeled Colloid Studies in Lymphatic Mapping for Breast Cancer at SNMMI Jun 10, 2013
Navidea Announces Data Presentations at 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Jun 4, 2013
Navidea Biopharmaceuticals Announces Highlights of Lymphoseek® Data Presented at Joint International Oncology Congress (JIOC) May 29, 2013
Navidea Biopharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference May 29, 2013
Navidea Biopharmaceuticals Announces the Presentation of Lymphoseek® Data at Joint International Oncology Congress (JIOC) May 22, 2013
